Skip to main content

Table 2 Treatment characteristics

From: Radiation field size and dose determine oncologic outcome in esophageal cancer

Treatment characteristics Pre-CRT (n = 25) Def-CRT group (n = 49) P value
n (%) n (%)
Radiation planning
 Conventional (2D) 10 40 20 41 0.95
 Conformal (3D) 15 60 29 59
Chemotherapy regimes
 Cisplatin + infusional 5-FU 5 20 10 20 0.7
 Weekly cisplatin 7 28 11 22
 Weekly cisplatin + oral UFT 8 32 16 33
 Weekly cisplatin + paclitaxel 3 12 7 14
 Paclitaxel + 5-FU 1 4 2 5
 Weekly cisplatin + capecitabine 1 4 3 6
Radiation dose (cGy)
 4000–5000 25 100 39 78 0.01
 5001–6000 0 0 11 22
  1. CRT chemoradiotherapy, UFT oral uracil + tegafur